Q3 2021 G1 Therapeutics Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the G1 Therapeutics Third Quarter 2021 Financial Results Conference Call. (Operator Instructions)
I would now like to turn the conference over to your speaker today, Will Roberts. Thank you. Please go ahead.
Thank you, Gail. Good morning, everyone, and welcome to the G1 conference call to discuss our third quarter 2021 financial results and business update. The press release on these financial results was issued this morning and can be found in the News section of our corporate website, g1therapeutics.com.
On this morning's call, the team will provide a business overview of the third quarter of 2021, including an update on our commercial progress in that period with COSELA, which was approved by the U.S. Food and Drug Administration on February 12, 2021, to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |